Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HANNA K GAGGIN

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1760597728
CMS profile
1239158
Location
BOSTON, MA

General Payments · PY2018–2024

$198,985.03

  • Reported across 175 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$58,629.80

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $22,551.29 5
PFIZER INC. $10,591.33 6
Novo Nordisk AS $8,912.50 4
Merck Sharp & Dohme Corporation $6,883.68 9
Acerta Pharma LLC $6,246.00 2
Alnylam Pharmaceuticals Inc. $2,820.00 1
Alexion Pharmaceuticals, Inc. $625.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $8,242.66 13
PY2019 $28,613.03 33
PY2020 $21,839.16 15
PY2021 $26,363.47 29
PY2022 $26,245.97 30
PY2023 $29,050.94 27
PY2024 $58,629.80 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $625.00 12/15/2024 Consulting Fee Undisputed 01/23/2026 1093950470 CMS
Alnylam Pharmaceuticals Inc. $2,820.00 09/29/2024 Consulting Fee Undisputed 01/23/2026 1125835879 CMS
AstraZeneca Pharmaceuticals LP $1,950.00 10/25/2024 Consulting Fee Undisputed 01/23/2026 1104423267 CMS
AstraZeneca Pharmaceuticals LP $4,296.00 11/27/2024 Consulting Fee Undisputed 01/23/2026 1105773772 CMS
Merck Sharp & Dohme LLC $77.09 11/11/2024 Food and Beverage Undisputed 01/23/2026 1141795054 CMS
Merck Sharp & Dohme LLC $185.02 11/11/2024 Travel and Lodging Undisputed 01/23/2026 1141899556 CMS
Merck Sharp & Dohme LLC $50.00 11/12/2024 Food and Beverage Undisputed 01/23/2026 1141795056 CMS
Merck Sharp & Dohme LLC $271.57 11/12/2024 Travel and Lodging Undisputed 01/23/2026 1141795058 CMS
Merck Sharp & Dohme LLC $65.00 11/12/2024 Food and Beverage Undisputed 01/23/2026 1141797593 CMS
Merck Sharp & Dohme LLC $30.00 11/12/2024 Food and Beverage Undisputed 01/23/2026 1141899558 CMS
Merck Sharp & Dohme LLC $150.00 11/20/2024 Travel and Lodging Undisputed 01/23/2026 1141604750 CMS
Merck Sharp & Dohme LLC $4,905.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1141604752 CMS
Merck Sharp & Dohme LLC $1,150.00 11/25/2024 Consulting Fee Undisputed 01/23/2026 1141653552 CMS
Novo Nordisk AS $247.86 05/27/2024 Travel and Lodging Undisputed 01/23/2026 1096551901 CMS
Novo Nordisk AS $196.80 05/27/2024 Food and Beverage Undisputed 01/23/2026 1096551973 CMS
Novo Nordisk AS $8,254.30 05/27/2024 Travel and Lodging Undisputed 01/23/2026 1096551989 CMS
Novo Nordisk AS $12,981.25 05/27/2024 Consulting Fee Undisputed 01/23/2026 1096552085 CMS
Novo Nordisk AS $871.08 05/27/2024 Travel and Lodging Undisputed 01/23/2026 1096552905 CMS
Novo Nordisk Inc $3,100.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 1097694247 CMS
Novo Nordisk Inc $387.50 12/10/2024 Consulting Fee Undisputed 01/23/2026 1096759460 CMS
Novo Nordisk Inc $2,712.50 12/10/2024 Consulting Fee Undisputed 01/23/2026 1096936137 CMS
Novo Nordisk Inc $2,712.50 12/11/2024 Consulting Fee Undisputed 01/23/2026 1097317671 CMS
PFIZER INC. $5,250.00 01/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132041009 CMS
PFIZER INC. $963.96 05/26/2024 Travel and Lodging Undisputed 01/23/2026 1131424914 CMS
PFIZER INC. $481.22 05/26/2024 Travel and Lodging Undisputed 01/23/2026 1131428240 CMS
PFIZER INC. $296.15 06/28/2024 Travel and Lodging Undisputed 01/23/2026 1132051492 CMS
PFIZER INC. $3,300.00 08/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132068919 CMS
PFIZER INC. $300.00 08/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132061596 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.